1301:TWSEFormosa Plastics Corporation Analysis
Data as of 2026-06-13 - not real-time
NT$45.25
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at 45.25 TWD, which sits below its 20‑day and 50‑day simple moving averages but remains above the 200‑day average, indicating a short‑term pullback within a longer‑term uptrend. RSI at 43 suggests neutral momentum, while the MACD histogram is negative and the signal line is bearish, reinforcing downside pressure. Volume has been increasing, supporting the recent price action, yet the 30‑day volatility of roughly 39% and a beta of 0.37 point to a stock that can swing sharply while being less correlated with the broader market. The market sentiment is extremely bullish, as reflected by a fear‑greed index of 89.86, but price is still far from the identified resistance near 53.4 TWD and near the support level of 43.1 TWD.
Fundamentally, the company posted an 11% revenue decline and negative gross, operating, and profit margins, with a trailing EPS loss of -1.58 TWD. Forward EPS is projected positive at 1.37 TWD, and analysts have a median price target of 60 TWD, implying upside potential. The balance sheet shows ample cash (133B TWD) but a very high debt load (154B TWD) resulting in a debt‑to‑equity ratio above 39, and free cash flow is negative, raising concerns about dividend sustainability despite a 1.1% yield. Valuation metrics are mixed: a low price‑to‑book of 0.74 suggests relative cheapness, yet the discounted cash‑flow fair value of just 8.1 TWD flags significant overvaluation relative to current price.
Fundamentally, the company posted an 11% revenue decline and negative gross, operating, and profit margins, with a trailing EPS loss of -1.58 TWD. Forward EPS is projected positive at 1.37 TWD, and analysts have a median price target of 60 TWD, implying upside potential. The balance sheet shows ample cash (133B TWD) but a very high debt load (154B TWD) resulting in a debt‑to‑equity ratio above 39, and free cash flow is negative, raising concerns about dividend sustainability despite a 1.1% yield. Valuation metrics are mixed: a low price‑to‑book of 0.74 suggests relative cheapness, yet the discounted cash‑flow fair value of just 8.1 TWD flags significant overvaluation relative to current price.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and price below short‑term SMAs
- High recent volatility
- Proximity to near‑term support at 43.1 TWD
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst price targets suggesting 15‑30% upside
- Forward EPS turning positive
- Low price‑to‑book ratio offering value exposure
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong asset base and low PB multiple
- Potential turnaround in margins as market conditions improve
- Strategic position in specialty chemicals despite regulatory headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth-11.10%
Profit Margin-4.01%
P/E Ratio33.0
ROE-2.01%
ROA-0.90%
Debt/Equity39.62
P/B Ratio0.7
Op. Cash FlowNT$7.9B
Free Cash FlowNT$-7135266816
Technical Analysis
TrendNeutral
RSI43.0
SupportNT$43.10
ResistanceNT$53.40
MA 20NT$46.66
MA 50NT$48.57
MA 200NT$43.43
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueNT$8.14
Target PriceNT$52.80
Upside/Downside16.69%
GradeOvervalued
TypeValue
Dividend Yield1.10%
Risk Assessment
Beta0.37
Volatility39.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.